Two Sigma Advisers
DBTX

Two Sigma Advisers’s Decibel Therapeutics, Inc. Common Stock DBTX Stock Holding History

Two Sigma Advisers’s Portfolio DBTX Stock Details DBTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-11,300
Closed -$53K – 2971
2021
Q4 		$53K Buy
+11,300
New +$77.8K ﹤0.01% 2470
2021
Q2 		– Sell
-15,100
Closed -$172K – 2762
2021
Q1 		$172K Buy
+15,100
New +$237K ﹤0.01% 2378

Other funds holding DBTX

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
HMC
Harvard Management Company Boston, Massachusetts $1.82B AUM 26.23% 1-Year Est. Return

Two Sigma Advisers's DBTX Position: Q1 2022 in Review

Two Sigma Advisers sold out of Decibel Therapeutics, Inc. Common Stock (DBTX) in Q1 2022, closing a stake of 11,300 shares — an estimated $53K sold.

Two Sigma Advisers first reported a position in DBTX in Q1 2021 and held it in 2 quarters. The position peaked at $172K in Q1 2021. 39 funds tracked by Wall St. Rank hold DBTX as of Q1 2022.

  • Two Sigma Advisers reported no remaining Decibel Therapeutics, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Two Sigma Advisers sold 11,300 Decibel Therapeutics, Inc. Common Stock shares in Q1 2022, an estimated $53K.
  • Two Sigma Advisers first reported a position in Decibel Therapeutics, Inc. Common Stock in Q1 2021 and held it in 2 quarters.
  • Two Sigma Advisers's Decibel Therapeutics, Inc. Common Stock position peaked at $172K in Q1 2021.
  • 39 funds tracked by Wall St. Rank held Decibel Therapeutics, Inc. Common Stock as of Q1 2022.

Based on Two Sigma Advisers's 13F filing for Q1 2022, filed 16 May 2022.